- eNewsletter from American Peptide Company

October 2009 - vol.1 no.2

President's Letter
Takahiro Ogata, President & COO

Hello!

Welcome to the second edition of The Peptide Wire, the American Peptide Company?s semi-annual e-newsletter. As our business continues to progress at an accelerated rate, we want to keep you constantly up to date on the latest developments that may affect you.

>> Read Full story


Technology Focus: PEGylation

Peptide ?based Active Pharmaceutical Ingredients (API) have tremendous therapeutic potential, but ?naked? peptides have certain limitations. Typical peptide drugs have low in vivo bioavailability and a circulating half-life measured in hours or even minutes.

>> Read Full story


Spotlight on New Partner - ABD Bioquest:

American Peptide Company is constantly pursuing opportunities to develop new technologies through partnerships and alliances in order to build our technology portfolio to offer a wider range of products to our customers.

>> Read Full Story


Win iPod touch and more:

Simply tell us what you think about American Peptide Company, and win iPod Touch! We will randomly select a winner from among the entries and send you the prize. (Please type the code: "pepwire_v1n2" in the comment of the survey or in the email subject.)

Good luck!

ipod_touch

>> Survey form
>> Email us


Visit our Website: www.americanpeptide.com

American Peptide Company, Inc.


Events & Tradeshows

CPhI Worldwide
Oct 13-15, Madrid, Spain
Booth # Hall 4/UPS 77

Neuroscience 2009
Oct 17-21, Chicago, IL
(Booth # 243)

AAPS Annual Meeting
Nov 9-11, Los Angeles, CA
(Booth # 2605)

ASCB
Dec 5-9, San Diego, CA
(Booth # 1138)

>> Other Shows
Ask the Experts:

Q & A: Peptides and Quality

The Peptide Wire speaks with APC?s resident expert on quality, Shawn Shirzadi, Vice President ? Quality.

>> Read more


In the News:

APC at CPhI Worldwide 2009
Laboratory Talk August 2009

Competition Mounting in Peptide Market
Genetic Engineering News Jul 1 2009 - Vol. 29, No. 13

Peptide Synthesis in Pharmaceutical Manufacturing
Pharmaceutical Processing July 2009

Expanding Business Development Team
ThomasNet News June 2009


This message was not sent unsolicited. Our records show that we have your permission to contact you via email. If you do not wish to receive further email messages from us, please reply to this message with "unsubscribe" as the subject line to administrator@americanpeptide.com.